Why the study?
Does non-invasive vagus nerve stimulation improve symptoms in patients with gastrointestinal disorders compared with sham stimulation?
Does non-invasive vagus nerve stimulation improve symptoms in patients with gastrointestinal disorders compared with sham stimulation?
Non-invasive VNS holds promise as a safe and effective therapy for improving symptoms in diverse gastrointestinal disorders, though larger studies are needed.
This is the authors' abstract. We don't add key points for this paper.
104), with a mean age ranging from 15 to 65 years. Non-invasive VNS significantly improved symptoms across all subsets of patients, as measured differently according to disease type, compared with sham stimulation. Adverse events, if reported, were low, with no serious complications. Putative mechanisms of action were assumed to be related to anti-inflammatory and anti-nociceptive effects. Non-invasive VNS holds promise as a safe therapy for diverse gastrointestinal disorders. However, these findings are derived from studies with small sample sizes and provide preliminary insights. Further research is warranted to define its exact position within the therapeutic arsenal.
Answers are grounded in this paper and cite their sources.
Supports non-invasive VNS for GI symptom relief; extends sham-controlled evidence across disorder subsets.
No takes yet. Share an insight, caveat, or question.
Veldman et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: